Surgery for recurrent biliary tract cancer: A single-center experience with 74 consecutive resections

Annals of Surgery

Volumn 262, Issue 1, 2015, Pages 121-129

  Takahashi, Yu ^a   Ebata, Tomoki ^a   Yokoyama, Yukihiro ^a   Igami, Tsuyoshi ^a   Sugawara, Gen ^a   Mizuno, Takashi ^a   Nimura, Yuji ^b   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Biliary tract cancer; Cholangiocarcinoma; Gallbladder cancer; surgery for recurrence

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE INTERVAL; FEMALE; GALLBLADDER CANCER; GASTROINTESTINAL SURGERY; HEPATOJEJUNOSTOMY; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PANCREATICODUODENECTOMY; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; VASCULAR SURGERY; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; GALLBLADDER NEOPLASMS; INTRAHEPATIC BILE DUCT; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84939431115     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000827     Document Type: Article

References (42)

1. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463-473.
2. Kayahara M, Nagakawa T, Nakagawara H, et al. Prognostic factors for gallbladder cancer in Japan. Ann Surg. 2008;248:807-814.
3. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84-96.
4. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholan-giocarcinoma. Ann Surg. 1999;230:808-818.
5. Sano T, Shimada K, Sakamoto Y, et al. One hundred two consecutive hepa-tobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240-247.
6. Kayahara M, Nagakawa T, Ohta T, et al. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg. 1999;229:76-83.
7. Shimada K, Nara S, Esaki M, et al. Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. Br J Surg. 2011;98:117-123.
8. Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarci-noma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689-1700.
9. Park JS, Yoon DS, Kim KS, et al. Actual recurrence patterns and risk factors influencing recurrence after curative resection with stage II gallbladder carcinoma. J Gastrointest Surg. 2007;11:631-637.
10. Kobayashi A, Miwa S, Nakata T, et al. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97: 56-64.
11. Jung SJ, Woo SM, Park HK, et al. Patterns of initial disease recurrence after resection of biliary tract cancer. Oncology. 2012;83:83-90.
12. Ramirez-Merino N, Aix SP, Cortes-Funes H. Chemotherapy for cholangiocar-cinoma: an update. World J Gastrointest Oncol. 2013;5:171-176.
13. Sasaki T, Isayama H, Nakai Y, et al. Current status of chemotherapy for the treatment of advanced biliary tract cancer. Korean J Intern Med. 2013;28:515-524.
14. Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer. 2007;96:896-902.
15. Zeng ZC, Tang ZY, Fan J, et al. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients. Cancer J. 2006;12:113-122.
16. Song SC, Heo JS, Choi DW, et al. Survival benefits of surgical resection in recurrent cholangiocarcinoma. J Korean Surg Soc. 2011;81:187-194.
17. Yamamoto M, Takasaki K, Otsubo T, et al. Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2001;8:154-157.
18. Ohtsuka M, Kimura F, Shimizu H, et al. Significance of repeated resection for recurrent intrahepatic cholangiocarcinoma. Hepatogastroenterology. 2009;56:1-5.
19. Ercolani G, Vetrone G, Grazi GL, et al. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010;252:107-114.
20. Kamphues C, Seehofer D, Eisele RM, et al. Recurrent intrahepatic cholangio-carcinoma: single-center experience using repeated hepatectomy and radiofre-quency ablation. J Hepatobiliary Pancreat Sci. 2010;17:509-515.
21. Saiura A, Yamamoto J, Kokudo N, et al. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg. 2011;201:203-208.
22. Sulpice L, Rayar M, Boucher E, et al. Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg. 2012;99:1711-1717.
23. Igami T, Ebata T, Yokoyama Y, et al. Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications. World J Surg. 2011;35:2501-2509.
24. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535-543.
25. Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 2000;7:155-162.
26. Igami T, Nishio H, Ebata T, et al. Surgical treatment of hilar cholangiocar-cinoma in the "new era": the Nagoya University experience. J Hepatobiliary Pancreat Sci. 2010;17:449-454.
27. Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for per-ihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129-140.
28. Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297-305.
29. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720-727.
30. Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115-123.
31. Ebata T, Nagino M, Nishio H, et al. Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg. 2007;31:2008-2015.
32. Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953-960.
33. Nimura Y, Hayakawa N, Kamiya J, et al. Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg. 1991;78:727-731.
34. Kondo S, Nimura Y, Hayakawa N, et al. Extensive surgery for carcinoma of the gallbladder. Br J Surg. 2002;89:179-184.
35. Takahashi Y, Nagino M, Nishio H, et al. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010;97:1860-1866.
36. Kleeff J, Reiser C, Hinz U, et al. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg. 2007;245:566-572.
37. Thomas RM, Truty MJ, Nogueras-Gonzalez GM, et al. Selective reoper-ation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg. 2012;16:1696-1704.
38. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemc-itabine for biliary tract cancer. N Engl J Med. 2010;362:1273-1281.
39. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364-372.
40. Nagino M, Kamiya J, Arai T, et al. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery. 2005;137:148-155.
41. Kamiya S, Nagino M, Kanazawa H, et al. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg. 2004;239:510-517.
42. Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706-714.